Background illustration for clinical trials search

Paid Clinical Trials Toronto

Discover 2,121 paid clinical trials in Toronto, Ontario. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma

for
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06485076

Recruiting

Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host

for
Colorectal Neoplasms, Colorectal Cancer, Breast Cancer,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT02732860

Recruiting

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

for
Solid Tumors
Location: Toronto, Ottawa, Hackensack NJ, Baltimore MD,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06179160

Phase 1, Recruiting

Talazoparib and Thoracic RT for ES-SCLC

for
Lung Cancer, Small-Cell Lung Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04170946

Phase 1, Recruiting

Virtual Rehabilitation for Cancer Survivors

for
Breast Cancer, Stage 0, Colorectal Cancer Stage I,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05898789

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

for
Breast Neoplasms, Breast Cancer
Location: Toronto, Kingston, Montreal, New Brunswick NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06686394

Phase 1, Phase 2, Recruiting

Is Adaptive SBRT for Prostate vs Image-guided Radiotherapy a True Evolution (ASPIRE)

for
Localized Prostate Cancer, Stereotactic Body Radiotherapy
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: Male

Age: 18+

Code: NCT06825091

Phase 3, Recruiting

A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection

for
Lung Cancer, Adjuvant, Post-surgical, EGFR, Exon 20,
Location: Toronto, Dearborn MI, Canton OH, New York NY,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07128199

Phase 3, Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

for
Prostatic Neoplasms, Castration-Resistant
Location: Toronto, Sterling Heights MI, Ottawa, Pittsburgh PA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07225946

Phase 3, Recruiting

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

for
Sarcoma,Soft Tissue
Location: Toronto, Farmington Hills MI, Columbus OH,
Sponsor: Intensity Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06263231

Phase 3, Recruiting

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: Toronto, Columbus OH, Boston MA, Chapel Hill NC,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07441694

Phase 1, Recruiting

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

for
Lymphoma, Non-Hodgkin, Lymphoma, Follicular,
Location: Toronto, Cleveland OH, Montreal, Nashville TN,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07519772

Phase 1, Phase 2, Recruiting

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

for
Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS
Location: Toronto, Ann Arbor MI, Grand Rapids MI, Baltimore MD,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07644559

Phase 2, Recruiting

Inhale and Exhale Breath Holds to Improve the Radiation Therapy Accuracy in People With Upper Abdominal Cancers

for
Abdominal Cancer
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07594691

Recruiting

STEP2 vs. Routine Early Palliative Care: Randomized Noninferiority Trial

for
Oncology
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07446660

Recruiting

Virtual Vs Telephone Education in Radiotherapy

for
Patient Education, Radiotherapy
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07255196

Recruiting

A Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Response and Resistance in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)

for
Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07408063

Phase 2, Recruiting

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

for
Bladder Cancer
Location: Toronto, Cleveland OH, Traverse City MI, Morristown NJ,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07419295

Phase 3, Recruiting

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Toronto, Montreal
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07491445

Phase 3, Recruiting

BAL Fluid Biomarkers in Sarcoma

for
Soft Tissue Sarcoma (STS), Bronchoalveolar Lavage (BAL),
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT06815666

Phase 2, Recruiting